Filing Details
- Accession Number:
- 0001140361-16-088328
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-01 12:17:56
- Reporting Period:
- 2016-11-29
- Filing Date:
- 2016-12-01
- Accepted Time:
- 2016-12-01 12:17:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1561387 | Health Insurance Innovations Inc. | HIIQ | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1366007 | Bruce Telkamp | C/O Health Insurance Innovations, Inc. 15438 N. Florida Ave., Suite 201 Tampa FL 33613 | Ceo Of Healthpocket, Inc.* | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2016-11-25 | 5,000 | $0.00 | 178,281 | No | 5 | G | Direct | |
Class A Common Stock | Acquisiton | 2016-11-29 | 10,000 | $4.95 | 188,281 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2016-11-29 | 3,853 | $12.85 | 184,428 | No | 4 | D | Direct | |
Class A Common Stock | Disposition | 2016-11-29 | 2,691 | $12.85 | 181,737 | No | 4 | F | Direct | |
Class A Common Stock | Disposition | 2016-11-29 | 3,456 | $12.85 | 178,281 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2016-11-30 | 5,000 | $0.00 | 173,281 | No | 5 | G | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 5 | G | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Appreciation Rights | Disposition | 2016-11-29 | 10,000 | $0.00 | 10,000 | $4.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,000 | 2022-07-01 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Appreciation Rights | $6.77 | 2021-05-25 | 84,000 | 84,000 | Direct | |
Class A Common Stock | Stock Appreciation Rights | $6.77 | 2021-05-25 | 42,000 | 42,000 | Direct | |
Class A Common Stock | Stock Appreciation Rights | $12.13 | 2021-07-14 | 10,000 | 10,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-05-25 | 84,000 | 84,000 | Direct |
2021-05-25 | 42,000 | 42,000 | Direct |
2021-07-14 | 10,000 | 10,000 | Direct |
Footnotes
- This transaction reports a donation to a 501(c)(3) public charity.
- On November 29, 2016, the reporting person exercised stock appreciation rights ("SARs") relating to 10,000 shares, of which 3,853 shares were retained by the issuer to satisfy the exercise price of such SARs, 2,691 shares were withheld by the issuer to satisfy a tax liability associated with the exercise, and 3,456 of the shares were sold by the reporting person.
- These stock-settled stock appreciation rights were granted under the Plan and will vest as follows: (i) 42,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $12.00 per share for the preceding 30 consecutive trading days, and (ii) 42,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $16.00 per share for the preceding 30 consecutive trading days, all subject to the terms of the Plan and an award agreement under the Plan.
- These stock-settled stock appreciation rights were previously granted under the Plan and will vest (either wholly or partially) based on the extent to which certain financial performance targets established by the Company's Board of Directors are achieved for the 2016 fiscal year.
- These stock-settled stock appreciation rights were previously granted under the Issuer's Long-Term Incentive Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
- These stock-settled stock appreciation rights were previously granted under the Issuer's Long-Term Incentive Plan (the "Plan") and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.